Blood Advances (Jul 2018)

Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury

  • Rick Kapur,
  • Michael Kim,
  • Johan Rebetz,
  • Björn Hallström,
  • Jonas T. Björkman,
  • Alisa Takabe-French,
  • Noel Kim,
  • Jonathan Liu,
  • Shanjeevan Shanmugabhavananthan,
  • Stefan Milosevic,
  • Mark J. McVey,
  • Edwin R. Speck,
  • John W. Semple

Journal volume & issue
Vol. 2, no. 13
pp. 1651 – 1663

Abstract

Read online

Abstract: Transfusion-related acute lung injury (TRALI) is a syndrome of respiratory distress upon blood transfusion and is the leading cause of transfusion-related fatalities. Whether the gut microbiota plays any role in the development of TRALI is currently unknown. We observed that untreated barrier-free (BF) mice suffered from severe antibody-mediated acute lung injury, whereas the more sterile housed specific pathogen-free (SPF) mice and gut flora-depleted BF mice were both protected from lung injury. The prevention of TRALI in the SPF mice and gut flora–depleted BF mice was associated with decreased plasma macrophage inflammatory protein-2 levels as well as decreased pulmonary neutrophil accumulation. DNA sequencing of amplicons of the 16S ribosomal RNA gene revealed a varying gastrointestinal bacterial composition between BF and SPF mice. BF fecal matter transferred into SPF mice significantly restored TRALI susceptibility in SPF mice. These data reveal a link between the gut flora composition and the development of antibody-mediated TRALI in mice. Assessment of gut microbial composition may help in TRALI risk assessment before transfusion.